Related references
Note: Only part of the references are listed.Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
Maya Balakrishnan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors
Akanksha Sharma et al.
HEPATOLOGY (2020)
Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet?fed mice
Shogo Takahashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
New drugs for non-alcoholic steatohepatitis
Ana-Carolina Cardoso et al.
LIVER INTERNATIONAL (2020)
Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis
Biki Gupta et al.
FASEB JOURNAL (2020)
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
Jean-Francois Dufour et al.
GUT (2020)
Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice
Anuradha Rao et al.
FRONTIERS IN MEDICINE (2020)
Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model
Keisuke Nakanishi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Evan Bolyen et al.
NATURE BIOTECHNOLOGY (2019)
Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy
Yanhai Feng et al.
PLOS ONE (2019)
Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs
Tiara R. Ahmad et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet
Shuangqi Li et al.
FOOD & FUNCTION (2019)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model
Kenichiro Seki et al.
Oncotarget (2018)
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
Toshihiro Goto et al.
SCIENTIFIC REPORTS (2018)
Recovery from an acute systemic and central LPS-inflammation challenge is affected by mouse sex and genetic background
Gabriela Meneses et al.
PLOS ONE (2018)
Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes
Henriette Hoist Nerild et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes
Andreas Bronden et al.
DIABETES OBESITY & METABOLISM (2018)
Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models
Mitsuaki Ishioka et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Contribution of anthocyanin-rich foods in obesity control through gut microbiota interactions
Giovana Jamar et al.
BIOFACTORS (2017)
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2017)
Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease
Shweta Kapil et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease
Brett M. McGettigan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
Len Verbeke et al.
SCIENTIFIC REPORTS (2016)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
LPS-induced TNF-a factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
Sara Ceccarelli et al.
ONCOTARGET (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
Akitoshi Douhara et al.
MOLECULAR MEDICINE REPORTS (2015)
MECHANISMS IN ENDOCRINOLOGY Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion
David P. Sonne et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication
Jan Kristoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
Matthew J. Potthoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
Anthony L. Guerrerio et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients
Juan F. Navarro-Gonzalez et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
Erwin Gäbele et al.
JOURNAL OF HEPATOLOGY (2011)
Plasma metabolomic profile in nonalcoholic fatty liver disease
Satish C. Kalhan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Sevelamer Carbonate Reduces Inflammation and Endotoxemia in an Animal Model of Uremia
Aline B. Hauser et al.
BLOOD PURIFICATION (2010)
Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor- and Liver X Receptorα-Controlled Metabolic Pathways in Mice
Hilde Herrema et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Rediscovering bile acid sequestrants
D. S. H. Bell et al.
DIABETES OBESITY & METABOLISM (2009)
Treatment of nonalcoholic steatohepatitis with colestimide
Makiko Taniai et al.
HEPATOLOGY RESEARCH (2009)
Endotoxin-binding affinity of sevelamer hydrochloride
Mary C. Perianayagam et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Species divergence and the measurement of microbial diversity
Catherine A. Lozupone et al.
FEMS MICROBIOLOGY REVIEWS (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin
Misato Kobayashi et al.
DIABETES (2007)
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB
T. Z. DeSantis et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats
V Lorenzo-Zúñiga et al.
HEPATOLOGY (2003)
Role of bile in intestinal barrier function and its inhibitory effect on bacterial translocation in obstructive jaundice in rats
Y Ogata et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Share Paper
